Abstract
A clinically acceptable modified erythrocyte concentrate with long shelf-life can now be readily provided even after complete removal of all available plasma for fractionation. The concentrates have been evaluated in an uneventful clinical trial.
Original language | English |
---|---|
Pages (from-to) | 635-637 |
Number of pages | 3 |
Journal | Medical Journal of Australia |
Volume | 1 |
Issue number | 12 |
DOIs | |
Publication status | Published - 1981 |
Externally published | Yes |